Holen Sie sich die Stockscreener-App
0.46
8.39%
-0.042
Schlusskurs vom Vortag:
$0.502
Offen:
$0.4678
24-Stunden-Volumen:
201.59K
Relative Volume:
0.39
Marktkapitalisierung:
$413.34K
Einnahmen:
$3,200
Nettoeinkommen (Verlust:
$-42.79M
KGV:
-0.000061
EPS:
-7534.7458
Netto-Cashflow:
$-25.70M
1W Leistung:
-23.00%
1M Leistung:
-74.73%
6M Leistung:
-99.90%
1J Leistung:
-99.98%
1-Tages-Spanne:
$0.44
$0.4738
1-Wochen-Bereich:
$0.44
$0.54
52-Wochen-Spanne:
$0.44
$2,594.48
Aditxt Inc Stock (ADTX) Company Profile
Firmenname
Aditxt Inc
Sektor
Branche
Telefon
909-488-0844
Adresse
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.457 | 454.04K | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
439.41 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
752.93 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.76 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.76 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aditxt Inc Aktie (ADTX) Neueste Nachrichten
Aditxt (NASDAQ: ADTX) registers 148.3M shares issuable on warrants - Stock Titan
Ignite Proteomics LLC Reports 2025 Financial Results and Acquisition by Aditxt, Inc - Minichart
12 Health Care Stocks Moving In Tuesday's Intraday Session - Sahm
Bull Bear: Can Aditxt Inc grow without dilution2026 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Ignite deal: Aditxt (NASDAQ: ADTX) records $36,551K goodwill - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Setup Watch: Can Aditxt Inc grow without external funding2026 Setups & Long-Term Safe Investment Plans - baoquankhu1.vn
ADTX | Aditxt, Inc. Common Stock Executive Compensation - Quiver Quantitative
Aditxt (NASDAQ: ADTX) seeks reverse stock split and say-on-pay nod - Stock Titan
Aditxt regains compliance with Nasdaq listing standards following equity increase - Investing.com
Aditxt regains Nasdaq compliance after equity rises to $3.95M - TradingView — Track All Markets
Aditxt (NASDAQ: ADTX) back in line with Nasdaq equity listing rules - Stock Titan
Aditxt 10-K: Revenue $0.003M, Net loss $42.79M, EPS $(1,153.83) - TradingView — Track All Markets
Heavy losses and Nasdaq risk at Aditxt (NASDAQ: ADTX) in 2025 10-K - Stock Titan
Aditxt, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aditxt Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Returns Recap: How does Aditxt Inc perform in inflationary periods2026 Institutional & Real-Time Volume Triggers - baoquankhu1.vn
Aditxt, Inc. Files Form 8-K for At-The-Market Offering—Key Details and Legal Opinion Included - Minichart
Aditxt increases at-the-market offering size by $36.8 million on Nasdaq - Investing.com
Aditxt increases ATM offering capacity by $36.8M, raising potential to $53.4M - TradingView
[8-K] Aditxt, Inc. Reports Material Event - Stock Titan
Trading Action: Does Aditxt Inc stock benefit from AI growth2026 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
ADTX (NASDAQ: ADTX) raises at‑the‑market capacity to $53.4M - stocktitan.net
Aditxt acquires Ignite Proteomics to expand precision oncology capabilities - MSN
Aditxt (ADTX) to vote on directors, auditor, say-on-pay, reverse split - Stock Titan
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
Travel Stocks: Should value investors consider Aditxt IncEarnings Growth Report & Proven Capital Preservation Methods - baoquankhu1.vn
If You Invested $1,000 in Aditxt Inc (ADTX) - Stock Titan
Aug Technicals: Can Aditxt Inc grow without dilutionCPI Data & Daily Entry Point Trade Alerts - baoquankhu1.vn
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary By Investing.com - Investing.com Canada
IMAC Surrenders Ignite Assets; Proposed $35 Million Sale to Aditxt and $36 Million Financing - TradingView
IMAC Holdings (BACK) gives up Ignite assets to satisfy defaulted notes and links $36M ADTX preferred deal - Stock Titan
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary - Investing.com
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer - marketscreener.com
Targets Report: What are the risks of holding Aditxt Inc2026 Snapshot & Safe Swing Trade Setup Alerts - baoquankhu1.vn
ADTX Technical Analysis | Trend, Signals & Chart Patterns | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Aditxt Finalizes Ignite Proteomics Acquisition, Strengthening Oncology Focus - The Globe and Mail
Aditxt acquires precision oncology firm Ignite Proteomics By Investing.com - Investing.com South Africa
Aditxt (ADTX) Acquires Ignite Proteomics, Shares Drop 37% - GuruFocus
Aditxt acquires Ignite Proteomics in $36M preferred stock deal; shares down - MSN
Aditxt Backs Acquisition of Ignite Proteomics - themiddlemarket.com
Aditxt acquires precision oncology firm Ignite Proteomics - Investing.com Nigeria
Aditxt (ADTX) Acquires Ignite Proteomics in $36M Stock Deal - GuruFocus
Aditxt Buys Ignite Proteomics for $36M in Preferred Stock and Secures $2.88M Note Financing - TradingView
Aditxt (NASDAQ: ADTX) buys Ignite Proteomics with $36M preferred stock, adds notes - Stock Titan
Aditxt cancer move: Ignite Proteomics to guide therapy for 600,000 - Stock Titan
Aditxt, Inc. acquired Ignite Proteomics LLC from IMAC Holdings, Inc. and others for approximately $36 million. - marketscreener.com
Finanzdaten der Aditxt Inc-Aktie (ADTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aditxt Inc-Aktie (ADTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Pankovcin Corinne | Chief M&A Officer |
Nov 25 '25 |
Sale |
3.20 |
1 |
3 |
0 |
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):